These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 3932411)
1. Thyrotoxicosis and Graves disease. Safran M; Braverman LE Hosp Pract (Off Ed); 1985 Mar; 20(3A):33-42, 46-9. PubMed ID: 3932411 [No Abstract] [Full Text] [Related]
2. [Ophthalmologic changes in hyperthyroidism]. Hagert M Z Gesamte Inn Med; 1971 Aug; 26(16):501-8. PubMed ID: 4110417 [No Abstract] [Full Text] [Related]
3. Laboratory examination of the thyroid. 1. In vitro tests. Schneider PB Postgrad Med; 1974 Aug; 56(2):91-6. PubMed ID: 4136847 [No Abstract] [Full Text] [Related]
4. [TSH anti-receptor antibodies in Graves' disease]. Sérgio MR; Godinho C; Guerra L; Agapito A; Fonseca F; Costa C Acta Med Port; 1996; 9(7-9):229-31. PubMed ID: 9005701 [TBL] [Abstract][Full Text] [Related]
6. [Thyroid gland inhibition test in patients with endocrine ophthalmic diseases]. Fellinger K; Bergmann H; Erd W; Höfer R; Kolarz G Wien Klin Wochenschr; 1971 Oct; 83(40):710-2. PubMed ID: 5170999 [No Abstract] [Full Text] [Related]
7. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study. Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575 [TBL] [Abstract][Full Text] [Related]
8. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants]. Gautier E; Juillard E; Lemarchand-Béraud T Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264 [No Abstract] [Full Text] [Related]
12. Soluble CD antigen (cytokine) expression in various hyperthyroid states and use in the assessment of propylthiouracil treatment. Murphy ED; Kallio P J Lab Clin Med; 1994 Aug; 124(2):255-62. PubMed ID: 8051490 [TBL] [Abstract][Full Text] [Related]
13. [Thyroid dysfunction in the aged]. Marañón Cabello A An Med Interna; 2000 Jan; 17(1):1-4. PubMed ID: 10730396 [No Abstract] [Full Text] [Related]
14. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995]. Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225 [TBL] [Abstract][Full Text] [Related]
16. [Neonatal hyperthyroidism in a premature infant born to a mother with Grave's disease]. Nicaise C; Gire C; Brémond V; Minodier P; Soula F; d'Ercole C; Palix C Arch Pediatr; 2000 May; 7(5):505-8. PubMed ID: 10855389 [TBL] [Abstract][Full Text] [Related]
17. The diagnosis and management of thyrotoxicosis associated with Graves' disease. Mazzaferri EL Med Times; 1972 Aug; 100(8):47-61 passim. PubMed ID: 4114172 [No Abstract] [Full Text] [Related]
18. [Hyperthyroidism in a premature infant due to transplacental passage of maternal thyrotropin receptor antibodies]. Rink T; Wieg C; Schroth HJ; Helisch A; Bertram U Nuklearmedizin; 1999; 38(5):156-9. PubMed ID: 10488483 [TBL] [Abstract][Full Text] [Related]
19. Humoral and genetic factors in thyrotoxic Graves disease and neonatal thyrotoxicosis. Green WL JAMA; 1976 Apr; 235(14):1449-50. PubMed ID: 946443 [No Abstract] [Full Text] [Related]
20. [The treatment of hyperthyroidism with and indication for radioactive iodine]. Klokke AR; van der Vijver JC Ned Tijdschr Geneeskd; 1995 Apr; 139(16):819-21. PubMed ID: 7537352 [No Abstract] [Full Text] [Related] [Next] [New Search]